This is a preprint.
High-throughput crystallographic fragment screening of Zika virus NS3 Helicase
- PMID: 38746241
- PMCID: PMC11092484
- DOI: 10.1101/2024.04.27.591279
High-throughput crystallographic fragment screening of Zika virus NS3 Helicase
Abstract
The Zika virus (ZIKV), discovered in Africa in 1947, swiftly spread across continents, causing significant concern due to its recent association with microcephaly in newborns and Guillain-Barré syndrome in adults. Despite a decrease in prevalence, the potential for a resurgence remains, necessitating urgent therapeutic interventions. Like other flaviviruses, ZIKV presents promising drug targets within its replication machinery, notably the NS3 helicase (NS3Hel) protein, which plays critical roles in viral replication. However, a lack of structural information impedes the development of specific inhibitors targeting NS3Hel. Here we applied high-throughput crystallographic fragment screening on ZIKV NS3Hel, which yielded structures that reveal 3D binding poses of 46 fragments at multiple sites of the protein, including 11 unique fragments in the RNA-cleft site. These fragment structures provide templates for direct design of hit compounds and should thus assist the development of novel direct-acting antivirals against ZIKV and related flaviviruses, thus opening a promising avenue for combating future outbreaks.
Keywords: NS3; Zika virus; flavivirus; fragment-screening; helicase.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11092484/bin/nihpp-2024.04.27.591279v1-f0001.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11092484/bin/nihpp-2024.04.27.591279v1-f0002.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11092484/bin/nihpp-2024.04.27.591279v1-f0003.gif)
Similar articles
-
Discovery of Novel Druggable Sites on Zika Virus NS3 Helicase Using X-ray Crystallography-Based Fragment Screening.Int J Mol Sci. 2018 Nov 20;19(11):3664. doi: 10.3390/ijms19113664. Int J Mol Sci. 2018. PMID: 30463319 Free PMC article.
-
Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery.J Biomol Struct Dyn. 2020 Oct;38(16):4827-4837. doi: 10.1080/07391102.2019.1689851. Epub 2019 Nov 14. J Biomol Struct Dyn. 2020. PMID: 31690231
-
In silico testing of flavonoids as potential inhibitors of protease and helicase domains of dengue and Zika viruses.PeerJ. 2022 Aug 4;10:e13650. doi: 10.7717/peerj.13650. eCollection 2022. PeerJ. 2022. PMID: 35945938 Free PMC article.
-
Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses.Curr Top Med Chem. 2022;22(29):2435-2462. doi: 10.2174/1568026623666221122121330. Curr Top Med Chem. 2022. PMID: 36415099 Review.
-
Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go.Pharmaceuticals (Basel). 2019 Aug 30;12(3):127. doi: 10.3390/ph12030127. Pharmaceuticals (Basel). 2019. PMID: 31480297 Free PMC article. Review.
References
-
- Barreto ML, Barral-Netto M, Stabeli R, Almeida-Filho N, Vasconcelos PFC, Teixeira M, Buss P, Gadelha PE. 2016. Zika virus and microcephaly in Brazil: a scientific agenda. The Lancet 387:919–921. - PubMed
-
- Baud D, Gubler DJ, Schaub B, Lanteri MC, Musso D. 2017. An update on Zika virus infection. The Lancet 390:2099–2109. - PubMed
-
- de Araújo TVB, Ximenes RA de A, Miranda-Filho D de B, Souza WV, Montarroyos UR, de Melo APL, Valongueiro S, de Albuquerque M de FPM, Braga C, Filho SPB, Cordeiro MT, Vazquez E, Cruz D di CS, Henriques CMP, Bezerra LCA, Castanha PM da S, Dhalia R, Marques-Júnior ETA, Martelli CMT, Rodrigues LC, Dhalia C, Santos M, Cortes F, Kleber de Oliveira W, Evelim Coelho G, Cortez-Escalante JJ, Campelo de Albuquerque de Melo CF, Ramon-Pardo P, Aldighieri S, Mendez-Rico J, Espinal M, Torres L, Nassri Hazin A, Van der Linden A, Coentro M, Santiago Dimech G, Siqueira de Assuncao R, Ismael de Carvalho P, Felix Oliveira V. 2018. Association between microcephaly, Zika virus infection, and other risk factors in Brazil: Final report of a case-control study. Lancet Infect Dis 18:328–336. - PubMed
-
- Barreto ML, Barral-Netto M, Stabeli R, Almeida-Filho N, Vasconcelos PF, Teixeira M, Buss P, Gadelha PE. 2016. Zika virus and microcephaly in Brazil: a scientific agenda. Lancet 387:919–921. - PubMed
-
- Ventura C V, Maia M, Bravo-Filho V, Gois AL, Belfort R. Jr. 2016. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 387:228. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources